Clonal evolution of high-risk chronic lymphocytic leukemia: a contemporary perspective

Marwan Cheng Kuang Kwok, Catherine J. Wu

Research output: Contribution to journalArticlepeer-review

23 Downloads (Pure)

Abstract

Clonal evolution represents the natural process through which cancer cells continuously search for phenotypic advantages that enable them to develop and expand within microenvironmental constraints. In chronic lymphocytic leukemia (CLL), clonal evolution underpins leukemic progression and therapeutic resistance, with differences in clonal evolutionary dynamics accounting for its characteristically diverse clinical course. The past few years have witnessed profound changes in our understanding of CLL clonal evolution, facilitated by a maturing definition of high-risk CLL and an increasing sophistication of next-generation sequencing technology. In this review, we offer a modern perspective on clonal evolution of high-risk CLL, highlighting recent discoveries, paradigm shifts and unresolved questions. We appraise recent advances in our understanding of the molecular basis of CLL clonal evolution, focusing on the genetic and non-genetic sources of intratumoral heterogeneity, as well as tumor-immune dynamics. We review the technological innovations, particularly in single-cell technology, which have fostered these advances and represent essential tools for future discoveries. In addition, we discuss clonal evolution within several contexts of particular relevance to contemporary clinical practice, including the settings of therapeutic resistance to CLL targeted therapy and immunotherapy, as well as Richter transformation of CLL to high-grade lymphoma.
Original languageEnglish
Article number790004
Number of pages22
JournalFrontiers in Oncology
Volume11
DOIs
Publication statusPublished - 16 Dec 2021

Keywords

  • chronic lymphocytic leukemia
  • clonal evolution
  • intratumoral heterogeneity
  • single-cell analysis
  • Richter syndrome

Fingerprint

Dive into the research topics of 'Clonal evolution of high-risk chronic lymphocytic leukemia: a contemporary perspective'. Together they form a unique fingerprint.

Cite this